Literature DB >> 1956138

[Coronary artery bypass graft stenosis suspected to be due to hemostatic agents: a case report].

Y Tomizawa1, M Endo, M Kitamura, A Shiikawa, Y Yagi, H Koyanagi.   

Abstract

A 66-year-old man had a CABG with a saphenous vein graft. During the surgery, oxidized cellulose and fibrin glue were used and left in place for hemostasis. Six months after the surgery, the first postoperative CAG was performed and a stenosis of the coronary bypass graft near the proximal anastomosis was found. The first PTCA was done and the stenosis was released. Re-stenosis was observed at the same site one year after the first PTCA and a second one was performed. Five years and nine months after the surgery, the patient started complaining of severe chest pain even though he was receiving medication. Graft stenosis at the same site was observed by CAG. A cyst 3 cm in diameter, with irregular wall thickness was found near the proximal portion of the bypass graft. Resection of the cyst and re-CABG was performed uneventfully. Microscopically, the cyst consisted of fibroblasts, small vessels, collagen fiber and giant cells and was diagnosed as granuloma. In the giant cells, oxidized cellulose fiber was observed. No comparable cases have been reported in the literature. Topical hemostatic agents were discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1956138

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  3 in total

Review 1.  Clinical benefits and risk analysis of topical hemostats: a review.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

Review 2.  Imaging appearance of topical haemostatic agents: pictorial review.

Authors:  Howard T Heller; Brett S Walker; Cheryl A Sadow; Mary C Frates
Journal:  Br J Radiol       Date:  2017-01-03       Impact factor: 3.039

3.  Surgicel® (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: A case report.

Authors:  Hao Wang; Ping Chen
Journal:  Oncol Lett       Date:  2013-02-28       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.